Whilst antibiotic misuse continues to present itself as a problem in livestock production, domestic animals are suffering from increased chronic gut health issues.
This has caused an influx of microbiome-targeted feed additives and therapeutics being accelerated to market to improve animal health, nutrition, performance and productivity. However, significant challenges remain in demonstrating the commercial value of these products, particularly when benchmarked against more traditional solutions.
Returning for a second year, this is your chance to explore best practice in product development, covering:
Causality of a healthy animal gut microbiome
Antibiotic stewardship and microbial alternatives
-omics approaches and data analytics
IP and regulatory strategy
Nutritional and therapeutic products in R and D
How to design study programs that demonstrate product efficacy and more!
You’ll learn how to streamline your product development process and deliver the needs of your customers, be they nutritional and therapeutic product developers, pet parents or livestock farmers.
Early booking, start-up rates and group discounts are available. Visit the website to find out more.
Register by Friday, August 2: USD 1699.0
Register by Friday, August 30: USD 1899.0
Register by Friday, September 20: USD 2099.0
Standard Pricing: USD 2299.0
Speakers: Megan Lyman, Vice President – Legal Affairs, Alexandria Real Estate Equities, Jess Jarett, Computational Biologist, AnimalBiome, Xandra Smith, Research Manager, Arm and Hammer Animal and Food Production, John Gregg, CEO, BalinBac Therapeutics, Arvind Kumar, Leader - Discovery Biology Research (Bacteriology and Parasitology) ERL, Global Vaccines and Biologics, Elanco, Jennifer Radosevich, Worldwide Director of Research, Hill’s Pet Nutrition, Malcolm Kendall, CEO, Microbiome Insights, Dari Brown, Senior Director, Livestock Technical Innovation, Purina Animal Nutrition, Matthew Koci, Associate Professor, Immunology, Virology and Host-Pathogen Interactions, NC State, Christian Maltecca, Professor of Quantitative Genetics and Breeding, North Carolina State University, Mirja Huhtinen, Animal Health Development Director, Orion Pharma R and D, Tim Johnson, Assistant Professor of Animal Sciences, Purdue University, Christopher Belnap, CEO, Resilient Biotics, Harry Paul, CEO, Tharos, Garret Suen, Associate Professor of Bacteriology, University of Wisconsin-Madison